122 related articles for article (PubMed ID: 27490973)
1. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.
Carbone F; Satta N; Montecucco F; Virzi J; Burger F; Roth A; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Lalive PH; Mach F; Fainardi E; Vuilleumier N
Eur J Clin Invest; 2016 Sep; 46(9):805-17. PubMed ID: 27490973
[TBL] [Abstract][Full Text] [Related]
2. CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes.
Mannic T; Satta N; Pagano S; Python M; Virzi J; Montecucco F; Frias MA; James RW; Maturana AD; Rossier MF; Vuilleumier N
Endocrinology; 2015 Dec; 156(12):4707-19. PubMed ID: 26393305
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
Vuilleumier N; Montecucco F; Spinella G; Pagano S; Bertolotto M; Pane B; Pende A; Galan K; Roux-Lombard P; Combescure C; Dallegri F; Mach F; Palombo D
Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
[TBL] [Abstract][Full Text] [Related]
4. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
[TBL] [Abstract][Full Text] [Related]
5. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients.
Satta N; Pagano S; Montecucco F; Gencer B; ; Mach F; Kaiser L; Calmy A; Vuilleumier N
J Infect; 2018 Feb; 76(2):186-195. PubMed ID: 29198606
[TBL] [Abstract][Full Text] [Related]
6. Leptin/adiponectin ratio predicts poststroke neurological outcome.
Carbone F; Burger F; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Bertolotto M; Dallegri F; Mach F; Fainardi E; Montecucco F
Eur J Clin Invest; 2015 Nov; 45(11):1184-91. PubMed ID: 26381386
[TBL] [Abstract][Full Text] [Related]
7. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
[TBL] [Abstract][Full Text] [Related]
9. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
[TBL] [Abstract][Full Text] [Related]
10. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
Vuilleumier N; Rossier MF; Pagano S; Python M; Charbonney E; Nkoulou R; James R; Reber G; Mach F; Roux-Lombard P
Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
[TBL] [Abstract][Full Text] [Related]
12. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
[TBL] [Abstract][Full Text] [Related]
13. Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Bastardot F; Hartley O; Montecucco F; Mach F; Waeber G; Vollenweider P; Vuilleumier N
Thromb Haemost; 2016 Sep; 116(4):764-71. PubMed ID: 27384400
[TBL] [Abstract][Full Text] [Related]
14. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
[TBL] [Abstract][Full Text] [Related]
15. Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up.
Liberale L; Montecucco F; Bonaventura A; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Fainardi E; Carbone F
Eur J Clin Invest; 2017 Oct; 47(10):702-710. PubMed ID: 28783210
[TBL] [Abstract][Full Text] [Related]
16. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
[TBL] [Abstract][Full Text] [Related]
17. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
Wick PA; Mombelli A; Pagano S; Moren X; Giannopoulou C; Mach F; Roux-Lombard P; Vuilleumier N
J Periodontal Res; 2013 Jun; 48(3):350-6. PubMed ID: 23050768
[TBL] [Abstract][Full Text] [Related]
18. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke.
Carbone F; Vuilleumier N; Burger F; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Mach F; Fainardi E; Montecucco F
Eur J Clin Invest; 2015 Jun; 45(6):579-86. PubMed ID: 25845543
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.
Liberale L; Montecucco F; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Mach F; Fainardi E; Carbone F
Eur J Clin Invest; 2016 Dec; 46(12):1053-1062. PubMed ID: 27759884
[TBL] [Abstract][Full Text] [Related]
20. Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals.
Lagerstedt JO; Dalla-Riva J; Marinkovic G; Del Giudice R; Engelbertsen D; Burlin J; Petrlova J; Lindahl M; Bernfur K; Melander O; Nilsson J; Schiopu A
J Intern Med; 2019 Jan; 285(1):49-58. PubMed ID: 30028049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
